Zhejiang Int'l Group Co.,Ltd. (SHE:000411)
China
· Delayed Price · Currency is CNY 10.62
+0.10 (0.95%)
Apr 29, 2026, 3:04 PM CST
Zhejiang Int'l Group Revenue
Zhejiang Int'l Group had revenue of 8.59B CNY in the quarter ending March 31, 2026, with 1.87% growth. This brings the company's revenue in the last twelve months to 33.84B, up 1.95% year-over-year. In the year 2025, Zhejiang Int'l Group had annual revenue of 33.68B with 0.98% growth.
Revenue (ttm)
33.84B
Revenue Growth
+1.95%
P/S Ratio
0.18
Revenue / Employee
11.01M
Employees
3,072
Market Cap
5.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.68B | 327.45M | 0.98% |
| Dec 31, 2024 | 33.35B | 1.30B | 4.05% |
| Dec 31, 2023 | 32.05B | 1.43B | 4.68% |
| Jan 1, 2023 | 30.62B | 3.89B | 14.55% |
| Jan 1, 2022 | 26.73B | 1.72B | 6.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Chongqing Lummy Pharmaceutical | 759.50M |
| Nanjing Pharmaceutical Group Company | 54.96B |
| Hangzhou Minsheng Healthcare | 827.65M |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Shandong Keyuan Pharmaceutical | 448.33M |
| Zhejiang Haisen Pharmaceutical | 532.26M |
| Shanghai InnoStar Bio-tech | 811.33M |